Breast cancer (BC) is a common cancer all over the world that affects women. BC is one of
the leading causes of cancer mortality in women, which today has decreased with the …

Ki67 is a proliferation marker. It has been proposed as a useful clinical marker for breast
cancer subtype classification, prognosis, and prediction of therapeutic response. But the …

Studies have suggested that hormone receptor and Ki67 expression in normal breast tissue
are associated with subsequent breast cancer risk. We examined the associations of breast …

Background The activation of insulin pathways is hypothesized to promote tumor growth and
worsen breast cancer survival. Sugar‐sweetened beverages (SSBs) can lead to a higher …

Menopause is a critical window of susceptibility for its sensitivity to endocrine disrupting
chemicals due to the decline of endogenous estrogen. Using a surgical menopausal …

Among the first found cancer-related long non-coding RNAs (lncRNAs), MALAT1 is one that
involves in the development and progression of some tumors. MALAT1 can be aberrantly …

MicroRNAs (miRNAs) are key regulators in the development and progression of
osteosarcoma (OS). Based on our previous microarray data, we found that miR-335 …

Background We examined the role of post-diagnostic coffee and tea consumption in relation
to breast cancer-specific and all-cause mortality among women with breast cancer in …

Background Enhancer of zeste homolog 2 (EZH2) is a polycomb-group protein that is
involved in stem cell renewal and carcinogenesis. In breast cancer, increased EZH2 …

The progesterone receptor (PR) regulates transcriptional programs that drive proliferation,
survival, and stem cell phenotypes. Although the role of native progesterone in the …